Novartis ( Novartis )


Novartis's picture

We want to discover, develop and successfully market innovative products to prevent and cure diseases, to ease suffering and to enhance the quality of life.

Novartis press release, blog etc

06/29/2018 - 15:40 Novartis receives positive CHMP opinion for Kymriah for treating two aggressive blood cancers, marking important medical advance for patients in Europe
06/29/2018 - 15:24 Novartis announces intention to seek shareholder approval for 100% spinoff of Alcon eye care devices business; initiates share buyback of up to USD 5 bn
06/28/2018 - 17:10 Novartis presents new data demonstrating long-term efficacy, safety and tolerability of Aimovig (erenumab) in patients with chronic and episodic migraine
06/26/2018 - 18:46 Novartis International AG: Global study by Novartis and European Migraine and Headache Alliance reveals 60% of employed people with severe migraine miss, on average, a week of work per month
06/25/2018 - 20:38 Novartis Clear about Psoriasis survey data highlights challenges psoriasis patients face to achieve goal of clear skin
06/17/2018 - 21:35 Novartis International AG: Alcon AcrySof IQ PanOptix trifocal intraocular lens shows superior visual performance in head-to-head trial post-cataract surgery
06/16/2018 - 13:27 Novartis JULIET trial of Kymriah demonstrates more than one-year durability of responses in adults with relapsed or refractory DLBCL
06/15/2018 - 09:29 Novartis study of real-world data concludes Jakavi is associated with a reduction in risk of death and dangerous blood clots for patients with rare blood cancer
06/15/2018 - 07:41 Sandoz presents new long-term and switching data for biosimilars Zessly (infliximab) and Erelzi (etanercept) in rheumatoid arthritis
06/15/2018 - 07:39 Novartis survey uncovers real-world impact of immune thrombocytopenia or ITP, a rare blood disease, on patients' quality of life
06/13/2018 - 09:10 Novartis presents data to advance understanding of the role of IL-17A and reinforce Cosentyx leadership in spondyloarthritis
06/07/2018 - 07:59 Novartis announces JCO publication of Lutathera NETTER-1 data showing significantly longer time to deterioration of key quality of life measures in patients with progressive midgut NETs
06/02/2018 - 19:07 Third Novartis Phase III trial shows Kisqali combination therapy significantly improves PFS in HR+/HER2- advanced breast cancer
06/01/2018 - 20:51 New Novartis data presented at ASCO find nearly half of CML patients treated with Tasigna remain in remission almost three years after stopping therapy
05/31/2018 - 20:06 Novartis receives positive CHMP opinion for Aimovig (erenumab) for the prevention of migraine
05/31/2018 - 19:43 Sandoz receives positive CHMP opinion for proposed biosimilar adalimumab
05/29/2018 - 19:34 FDA expedites review of Novartis drug Promacta for first-line severe aplastic anemia (SAA)
05/28/2018 - 05:30 Novartis International AG: Patient-reported outcomes tool revealed significant improvement in symptom frequency and quality of life domains with Entresto